The device is placed in the targeted area, where it emits laser energy that heats the fat cells, causing them to release their contents
Esslinger, a board-certified internal medicine specialist with nearly 20 years experience prescribing GLP-1 medications
CJC-1295 is not FDA-approved for any medical use and is used off-label in clinical settings
The safety profile of the combination reflects the individual safety profiles of each component
This product has not been evaluated by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease
And in 2025, Wegovy also received FDA accelerated approval for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, underscoring that these medications can impact disease processes well beyond body weight alone